Rosiglitazone maleate

A potent, selective activity-dependent blocker of NMDA receptors containing the NR2B subunit (IC₅₀ = 9 nM) displays neuroprotectant effects in cortical neurons in vitro (IC₅₀ = 0.04-0.4 &muM).

A potent, selective activity-dependent blocker of NMDA receptors containing the NR2B subunit (IC₅₀ = 9 nM) displays neuroprotectant effects in cortical neurons in vitro (IC₅₀ = 0.04-0.4 &muM).

InformationRO8994 is a potent and selective spiroindolinone small-molecule MDM2 inhibitor with IC50 of 5 nM and 20 nM in HTRF binding assays and MTT proliferation assays, respectively.

InformationRosiglitazone maleate (BRL 49653), a member of the thiazolidinedione class of antihyperglycaemic agents, is a high-affinity selective agonist of theperoxisome proliferator-activated receptor-γ (PPAR-γ)with IC50 of 42 nM. Rosiglitazone

A potent and selective PPAR&gamma ligand, binding to the PPAR&gamma ligand-binding domain with a Kd value of 43 nM.

A potent and selective PPAR&gamma ligand, binding to the PPAR&gamma ligand-binding domain with a Kd value of 43 nM.

A potent and selective PPAR&gamma ligand, binding to the PPAR&gamma ligand-binding domain with a Kd value of 43 nM.

Rosiglitazone maleate

Rosiglitazone maleate

Recombinant human RSK2, full-length with an N-terminal His6 tag between Met1 and Pro2 Packaging Also available in 250 &#181g size --call for pricing and availability and reference catalog number 14-480M when ordering the 250 &#181g size. Quality

Rugonersen (RG6091: RO7248824) is a locked-nucleic acid (LNA)- modified antisense oligonucleotides (ASOs), and results in reduction of ubiquitin-protein ligase E3A (UBE3A) silencing. Angelman syndrome (AS) is a severe neurodevelopmental disorder

Rugonersen (RG6091: RO7248824) is a locked-nucleic acid (LNA)- modified antisense oligonucleotides (ASOs), and results in reduction of ubiquitin-protein ligase E3A (UBE3A) silencing. Angelman syndrome (AS) is a severe neurodevelopmental disorder